Inhibition of S6 Kinase activity for the treatment of insulin resistance
This invention provides screening methods for agents effective in treating insulin resistance through specific inhibition of S6 kinase 1 activity. Also provided are methods of treating insulin resistance by administering an effective amount of an inhibitor specific for S6 kinase 1
34216100
Applicant(s): Novartis Forschungsstiftung [CH]
Alternative title(s) : (de) Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz (fr) Inhibition de l'activite de la kinase s6 pour traiter la resistance a l'insuline (en) Inhibition of s6 kinase activity for the treatment of insulin resistance
Patent number | Country code | Kind code | Date issued |
ES2331006 | ES | T3 | 2009-12-18 |
DE602004022423 | DE | D1 | 2009-09-17 |
AT438859 | AT | T | 2009-08-15 |
EP1658504 | EP | B1 | 2009-08-05 |
US2007191259 | US | A1 | 2007-08-16 |
JP2007503203 | JP | A | 2007-02-22 |
EP1658504 | EP | A1 | 2006-05-24 |
WO2005019829 | WO | A1 | 2005-03-03 |